Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Jill Dimond"'
Autor:
Katherine D. Crew, Thomas B. Silverman, Alejandro Vanegas, Meghna S. Trivedi, Jill Dimond, Jennie Mata, Margaret Sin, Tarsha Jones, Mary Beth Terry, Wei-Yann Tsai, Rita Kukafka
Publikováno v:
Contemporary Clinical Trials Communications, Vol 16, Iss , Pp - (2019)
Background: Chemoprevention using selective estrogen receptor modulators and aromatase inhibitors has been shown to reduce invasive breast cancer incidence in high-risk women. Despite this evidence, few high-risk women who are eligible for chemopreve
Externí odkaz:
https://doaj.org/article/4b15d18f76774134b14f1b733653ded8
Autor:
Katherine D. Crew, Gauri Bhatkhande, Thomas Silverman, Jacquelyn Amenta, Tarsha Jones, Julia E. McGuinness, Jennie Mata, Ashlee Guzman, Ting He, Jill Dimond, Wei-Yann Tsai, Rita Kukafka
Publikováno v:
Cancer Prev Res (Phila)
Significant underutilization of breast cancer chemoprevention remains, despite guidelines stating that physicians should recommend chemoprevention with antiestrogen therapy to high-risk women. We randomized women, ages 35 to 75 years, who met high-ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fb6f37ce27068ac5c3b8e21a088ea87
https://doi.org/10.1158/1940-6207.capr-22-0013
https://doi.org/10.1158/1940-6207.capr-22-0013
Autor:
Rita Kukafka, Samuel Pan, Thomas Silverman, Tianmai Zhang, Wendy K. Chung, Mary Beth Terry, Elaine Fleck, Richard G. Younge, Meghna S. Trivedi, Julia E. McGuinness, Ting He, Jill Dimond, Katherine D. Crew
Publikováno v:
JAMA network open. 5(7)
To promote the identification of women carrying BRCA1/2 variants, the US Preventive Services Task Force recommends that primary care clinicians screen asymptomatic women for an increased risk of carrying a BRCA1/2 variant risk.To examine the effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97b7d3ad4c34bf9f37d020bc3a658b20
https://pubmed.ncbi.nlm.nih.gov/35849397
https://pubmed.ncbi.nlm.nih.gov/35849397
Autor:
Thomas Silverman, Jill Dimond, Ting He, Katherine D. Crew, Tarsha Jones, Gauri Bhatkhande, Jennie Mata, Rita Kukafka, Ashlee Guzman
Publikováno v:
Cancer Research. 81:PS8-11
Background: Less than 10 % of those identified as eligible for clinical trials are recruited. Recruitment for chemoprevention trials poses challenges as it is often difficult to identify unaffected patients at high risk for cancer. Barriers to recrui
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a94e8070bca3dfc2fd1a5c43bc76de9
https://doi.org/10.1158/1538-7445.sabcs20-ps8-11
https://doi.org/10.1158/1538-7445.sabcs20-ps8-11
Autor:
Julia E, McGuinness, Tianmai M, Zhang, Kevin, Cooper, Arusha, Kelkar, Jill, Dimond, Virginia, Lorenzi, Katherine D, Crew, Rita, Kukafka
Publikováno v:
AMIA Annu Symp Proc
Women at high risk for breast cancer may benefit from enhanced screening and risk-reduction strategies. However, limited time during clinical encounters is one barrier to routine breast cancer risk assessment. We evaluated if electronic health record
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::15fafe7303f30c30feff0cb7e46fbc93
https://pubmed.ncbi.nlm.nih.gov/35308910
https://pubmed.ncbi.nlm.nih.gov/35308910
Yes: Affirmative Consent as a Theoretical Framework for Understanding and Imagining Social Platforms
Autor:
Melody Berton, Katherine Mustelier, Eric Gilbert, Una Lee, Jill Dimond, Jane Im, Mark S. Ackerman
Publikováno v:
CHI
Affirmative consent is the idea that someone must ask for, and earn, enthusiastic approval before interacting with someone else. For decades, feminist activists and scholars have used affirmative consent to theorize and prevent sexual assault. In thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e93ed70983b2f82dc2e820893f2545a1
https://doi.org/10.1145/3411764.3445778
https://doi.org/10.1145/3411764.3445778
Autor:
Margaret Sin, Katherine D. Crew, Tarsha Jones, Meghna S. Trivedi, Wei-Yann Tsai, Jennie Mata, Mary Beth Terry, Thomas Silverman, Alejandro Vanegas, Jill Dimond, Rita Kukafka
Publikováno v:
Contemporary Clinical Trials Communications, Vol 16, Iss, Pp-(2019)
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications
Background: Chemoprevention using selective estrogen receptor modulators and aromatase inhibitors has been shown to reduce invasive breast cancer incidence in high-risk women. Despite this evidence, few high-risk women who are eligible for chemopreve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac7797504b00b470c3d5b30d36be52f4
http://www.sciencedirect.com/science/article/pii/S2451865419301954
http://www.sciencedirect.com/science/article/pii/S2451865419301954
Publikováno v:
Proceedings of the ACM on Human-Computer Interaction. 1:1-19
Online harassment is a pervasive and pernicious problem. Techniques like natural language processing and machine learning are promising approaches for identifying abusive language, but they fail to address structural power imbalances perpetuated by a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e9e42bdeb5a1dae7dfe0179e3c77ccb
https://doi.org/10.1145/3134659
https://doi.org/10.1145/3134659
Autor:
Thomas B, Silverman, Gilad J, Kuperman, Alejandro, Vanegas, Margaret, Sin, Jill, Dimond, Katherine D, Crew, Rita, Kukafka
Publikováno v:
AMIA ... Annual Symposium proceedings. AMIA Symposium. 2018
The United States Preventive Services Taskforce recommends that primary care providers screen patients for an increased risk of carrying a BRCA1 or BRCA2 mutation and refer those who meet family history criteria to genetic counseling. Such screening
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c1800343ae41e1e1becd15bcedab3ea5
https://pubmed.ncbi.nlm.nih.gov/30815139
https://pubmed.ncbi.nlm.nih.gov/30815139
Autor:
Rita Kukafka, Ting He, Thomas Silverman, Katherine D. Crew, Ashlee Guzman, Jill Dimond, Tarsha Jones, Gauri Bhatkhande, Jennie Mata
Publikováno v:
Cancer Research. 81:PS8-05
Background: Breast cancer chemoprevention with selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) have been shown in randomized controlled trials to reduce breast cancer incidence by 50-65% among high-risk women. However, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f78ccbfcd19c65d5e72d6da404c3bb50
https://doi.org/10.1158/1538-7445.sabcs20-ps8-05
https://doi.org/10.1158/1538-7445.sabcs20-ps8-05